Israel Cancer Research Fund - Chicago Chapter

Israel Cancer Research Fund - Chicago Chapter ICRF provides pivotal grants to outstanding Israeli scientists to support groundbreaking cancer research across Israel.

Israel Cancer Research Fund (ICRF) is a nationwide charitable organization that receives its total income from private donations. ICRF was founded in 1975 by a group of American and Canadian researchers, oncologists, and lay people determined to harness Israel's educational and scientific resources in the fight against cancer. Its initial purpose was to stem the "brain drain" of Israeli researcher

s by providing funds for postdoctoral fellowships for young Ph.D.'s. ICRF is the only U.S.-based charity solely devoted to supporting cancer research in Israel. Since its inception, ICRF has provided more than $72 million in funding to support innovative studies by Israeli scientists. Our awardees are selected through a rigorous peer-review process that is conducted by a world-class scientific panel. We support individuals at all of the major research institutions in Israel. ICRF-funded researchers have been making significant progress and have been able to develop improved chemotherapies, advanced techniques in bone marrow transplantation, and an enhanced understanding of tumor suppressor genes. By continuing to support cancer research in Israel for the benefit of all mankind, the ICRF:

makes it possible for scientists to utilize Israel's unique population of diverse ethnic groups which afford unequalled opportunities to study genetic and environmental data that contribute to cancer;

places a strong emphasis on young scientists pioneering in new directions with fresh approaches to areas of research that have challenged the experts;

respects and draws upon Israel's unparalleled convergence of some of the finest scientists and physicians in the free world - a resource that must not be lured to conduct research outside Israel.

Meet Prof. Rachel Grossman, an ICRF-funded researcher working to change how we monitor brain tumors.Glioblastoma is one ...
09/03/2026

Meet Prof. Rachel Grossman, an ICRF-funded researcher working to change how we monitor brain tumors.

Glioblastoma is one of the hardest cancers to treat, in part because the blood-brain barrier makes it difficult to detect tumor signals through a blood test.

Prof. Grossman and her team are exploring how MRI-guided focused ultrasound could temporarily open this barrier, creating a “window into the brain” that may allow doctors to monitor tumors through blood samples instead of surgery.

Research like this starts with bold ideas in the lab. With ICRF funding, those ideas can move closer to the patients who need them.

Learn more about Prof. Grossman's research here: https://www.icrfonline.org/news/science-made-simple-understanding-brain-cancer-with-professor-rachel-grossman/

You’re invited! Join us for the ICRF Chicago Tower of Hope Gala on Wednesday, October 28, for an inspiring evening celeb...
09/03/2026

You’re invited! Join us for the ICRF Chicago Tower of Hope Gala on Wednesday, October 28, for an inspiring evening celebrating science, Israeli innovation, and hope.

Registration is now open, with tickets, tributes, and sponsorships available. The evening will feature acclaimed storyteller, best-selling author, and two-time cancer survivor Tania Katan.

We’ll also present the inaugural David Abramson Memorial Award, honoring David’s lasting legacy and commitment to ICRF’s mission.

Join us in supporting cancer research discoveries that start in Israel and save lives worldwide.

Register today: https://my.onecause.com/event/organizations/08ce6e02-a029-47e9-8826-108717dea6a9/events/vevt:dd3e7267-3473-450e-8e63-46de7405c142/home/story

Our September newsletter is here! Explore the latest from ICRF-funded researchers and the discoveries shaping the future...
09/01/2026

Our September newsletter is here! Explore the latest from ICRF-funded researchers and the discoveries shaping the future of cancer research.

Inside this month’s issue:
- 38 new cancer research grants totaling $5.35 million
- A new genetic approach to tracking pediatric acute myeloid leukemia (AML)
- Science Made Simple with Prof. Rachel Grossman
- Nobel Laureate Prof. Aaron Ciechanover’s research exploring new treatments for blood cancers
- New findings on aging, immunotherapy, and machine learning
- Research Roundup: Recent peer-reviewed publications from ICRF grantees
- A look at two upcoming golf outings

Explore the grants, events, and groundbreaking research moving cancer research forward with ICRF.

Read the full September newsletter: https://conta.cc/4cgRMP5

Did you know appendix cancer is often discovered unexpectedly during surgery for suspected appendicitis? August is Appen...
08/27/2026

Did you know appendix cancer is often discovered unexpectedly during surgery for suspected appendicitis?

August is Appendix Cancer Awareness Month, a time to shine a light on this rare disease and the research needed to better understand it, detect it earlier, and develop more personalized treatments.

ICRF leads the way in research into rare cancers, as well as gastrointestinal and colorectal cancers, tumor metastasis, and other key biological mechanisms relevant to appendix cancer. Every discovery propels us toward better outcomes for patients facing all types of cancer.

We are proud to announce 38 new research grants supporting Israeli scientists pursuing innovative approaches to cancer p...
08/25/2026

We are proud to announce 38 new research grants supporting Israeli scientists pursuing innovative approaches to cancer prevention, detection, diagnosis, and treatment.

From AI and advanced imaging to liquid biopsy, genomics, microbiome research, immunotherapy, and precision medicine, these grants reflect the extraordinary breadth of cancer research across Israel.

Since 1975, ICRF has invested nearly $109 million in more than 3,000 cancer research grants, helping advance discoveries and improve patient care worldwide.

Learn more about the new grants and their recipients: https://www.icrfonline.org/new-grant-recipients-2026-2027-funding-year/

Be Part of the 4th Annual Drive Fore Research Golf Classic - September 14 🏌🏼Israel Cancer Research Fund ICRF & Rolfe Pan...
08/21/2026

Be Part of the 4th Annual Drive Fore Research Golf Classic - September 14 🏌🏼

Israel Cancer Research Fund ICRF & Rolfe Pancreatic Cancer Foundation are excited for another incredible day supporting cancer research.

Foursomes are sold out, but there are still many meaningful ways to participate.

⛳️ Become a Sponsor - Show your organization’s commitment to advancing cancer research.

⛳️ Purchase a Commemorative Tee Sign - Honor or remember someone special while supporting this important cause.

⛳️ Make a Donation - Help fuel groundbreaking research and bring us closer to a cancer-free future.

Learn more: https://www.icrfonline.org/events/event/chicago-drive-fore-research-golf-classic-2026/

And stay tuned for details about our silent auction, available digitally and at the event.

Together, we can drive research forward.

Have you explored our new website yet?Our refreshed website makes it easier to discover groundbreaking Israeli cancer re...
08/19/2026

Have you explored our new website yet?

Our refreshed website makes it easier to discover groundbreaking Israeli cancer research, meet our grantees, read about ICRF-funded science in the news, find events, and see how your support makes an impact on patients worldwide.

View it here: https://www.icrfonline.org/

Prof. Lucio Frydman of the Weizmann Institute of Science and Prof. Irit Ben-Aharon of Rambam Health Care Campus have rec...
08/17/2026

Prof. Lucio Frydman of the Weizmann Institute of Science and Prof. Irit Ben-Aharon of Rambam Health Care Campus have received ICRF Professorship Awards for the 2026-2027 funding year. While these honors recognize their exceptional contributions to cancer research, they also tell a larger story: how ICRF's investment in outstanding scientists over time drives more discovery.

Read more here: https://www.icrfonline.org/news/two-scientists-reflect-the-power-of-icrfs-investment/

ICRF-funded researcher Prof. Neta Erez and her team recently published in the journal Cancer Research. Their study uncov...
08/11/2026

ICRF-funded researcher Prof. Neta Erez and her team recently published in the journal Cancer Research. Their study uncovered new insights into how high-grade serous ovarian cancer spreads and how the tumor environment enables disease progression. This work advances our understanding of the processes behind metastasis and highlights the potential for new therapeutic strategies to improve patient outcomes.

Read More: https://www.icrfonline.org/news/icrf-funded-study-shows-new-insights-into-cancer-metastasis/

World Lung Cancer Day was recently observed on August 1, reminding us of the importance of advancing research to improve...
08/06/2026

World Lung Cancer Day was recently observed on August 1, reminding us of the importance of advancing research to improve outcomes for people affected by this challenging disease.

Dr. Brian Henick of Columbia University Irving Medical Center and a former member of ICRF’s Scientific Review Panel shares his insights on how research is transforming lung cancer care today and what he believes holds the greatest promise for the future of treatment.

Read more here: https://www.icrfonline.org/news/science-made-simple-understanding-lung-cancer-with-dr-brian-henick/

Address

One Northfield Plaza, #235
Northfield, IL
60093

Opening Hours

Monday 8am - 4pm
Tuesday 8am - 4pm
Wednesday 8am - 4pm
Thursday 8am - 4pm
Friday 8am - 4pm

Telephone

+18474411824

Website

Alerts

Be the first to know and let us send you an email when Israel Cancer Research Fund - Chicago Chapter posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Israel Cancer Research Fund - Chicago Chapter:

Shortcuts

Share